eli lilly gip/glp-1 touts new weight-loss shot, says stronger than old GLP-1s glp 1 zepbound Eli Lilly's

Germline signals deploy NHR-49 to modulate fatty-acid -oxidation and desaturation in somatic tissues of C

Individual responses vary considerably, and some patients continue experiencing specific food cravings despite effective appetite suppression

In recent years, we have witnessed a paradigm shift in cardiometabolic medicine: The SELECT trial demonstrated that GLP-1 receptor agonists reduce cardiovascular events even in patients without diabetes

Correct stapling technique in laparoscopic sleeve gastrectomy: are we increasing the bleeding

You can STOP messaging by sending STOP and get more help by sending HELP